Barnes, C.A. (1979) Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol, 93, 74-104.

Bell, K.A., O'Riordan, K.J., Sweatt, J.D. & Dineley, K.T. (2004) MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time. J Neurochem, 91, 349-361.

Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G. & Silva, A.J. (1994) Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell, 79, 59-68.

Breijyeh, Z. & Karaman, R. (2020) Comprehensive review on Alzheimer's Disease: causes and treatment. Molecules, 25.

Brewer, G.J. & Torricelli, J.R. (2007) Isolation and culture of adult neurons and neurospheres. Nat Protoc, 2, 1490-1498.

Bukke, V.N., Archana, M., Villani, R., Romano, A.D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G. & Cassano, T. (2020) The dual role of glutamatergic neurotransmission in Alzheimer's disease: From pathophysiology to pharmacotherapy. Int J Mol Sci, 21.

Chasseigneaux, S., Dinc, L., Rose, C., Chabret, C., Coulpier, F., Topilko, P., Mauger, G. & Allinquant, B. (2011) Secreted amyloid precursor protein β and secreted amyloid precursor protein α induce axon outgrowth in vitro through Egr1 signaling pathway. PLoS One, 6, e16301.

Chen, G.F., Xu, T.H., Yan, Y., Zhou, Y.R., Jiang, Y., Melcher, K. & Xu, H.E. (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin, 38, 1205-1235.

Cheng, I.H., Scearce-Levie, K., Legleiter, J., Palop, J.J., Gerstein, H., Bien-Ly, N., Puoliväli, J., Lesné, S., Ashe, K.H., Muchowski, P.J. & Mucke, L. (2007) Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem, 282, 23818-23828.

Cho, E.J., Kim, H.Y. & Lee, A.Y. (2020) Paeoniflorin ameliorates Aβ-stimulated neuroinflammation via regulation of NF-κB signaling pathway and Aβ degradation in C6 glial cells. Nutr Res Pract, 14, 593-605.

De Felice, F.G., Velasco, P.T., Lambert, M.P., Viola, K., Fernandez, S.J., Ferreira, S.T. & Klein, W.L. (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem, 282, 11590-11601.

Dhanasekaran, D.N. & Reddy, E.P. (2008) JNK signaling in apoptosis. Oncogene, 27, 6245-6251.

Dineley, K.T., Westerman, M., Bui, D., Bell, K., Ashe, K.H. & Sweatt, J.D. (2001) Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci, 21, 4125-4133.

Erickson, M.A., Maramara, L.A. & Lisman, J. (2010) A single brief burst induces GluR1-dependent associative short-term potentiation: a potential mechanism for short-term memory. J Cogn Neurosci, 22, 2530-2540.

Esposito, Z., Belli, L., Toniolo, S., Sancesario, G., Bianconi, C. & Martorana, A. (2013) Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? CNS Neurosci Ther, 19, 549-555.

Hunter, S., Arendt, T. & Brayne, C. (2013) The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD. Mol Neurobiol, 48, 556-570.

Karl, T., Bhatia, S., Cheng, D., Kim, W.S. & Garner, B. (2012) Cognitive phenotyping of amyloid precursor protein transgenic J20 mice. Behav Brain Res, 228, 392-397.

Kim, E.K. & Choi, E.J. (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta, 1802, 396-405.

Kim, S.H., Lee, M.K., Lee, K.Y., Sung, S.H., Kim, J. & Kim, Y.C. (2009) Chemical constituents isolated from Paeonia lactiflora roots and their neuroprotective activity against oxidative stress in vitro. J Enzyme Inhib Med Chem, 24, 1138-1140.

Kogan, J.H., Frankland, P.W., Blendy, J.A., Coblentz, J., Marowitz, Z., Schütz, G. & Silva, A.J. (1997) Spaced training induces normal long-term memory in CREB mutant mice. Curr Biol, 7, 1-11.

Leger, M., Quiedeville, A., Bouet, V., Haelewyn, B., Boulouard, M., Schumann-Bard, P. & Freret, T. (2013) Object recognition test in mice. Nat Protoc, 8, 2531-2537.

Lustbader, J.W., Cirilli, M., Lin, C., Xu, H.W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., Trinchese, F., Liu, S., Gunn-Moore, F., Lue, L.F., Walker, D.G., Kuppusamy, P., Zewier, Z.L., Arancio, O., Stern, D., Yan, S.S. & Wu, H. (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science, 304, 448-452.

Ma, X., Song, M., Yan, Y., Ren, G., Hou, J., Qin, G., Wang, W. & Li, Z. (2021) Albiflorin alleviates cognitive dysfunction in STZ-induced rats. Aging (Albany NY), 13, 18287-18297.

Mayr, B. & Montminy, M. (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol, 2, 599-609.

Meilandt, W.J., Yu, G.Q., Chin, J., Roberson, E.D., Palop, J.J., Wu, T., Scearce-Levie, K. & Mucke, L. (2008) Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease. J Neurosci, 28, 5007-5017.

Morris, R. (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods, 11, 47-60.

Morrison, D.K. (2012) MAP kinase pathways. Cold Spring Harb Perspect Biol, 4.

Mucke, L., Masliah, E., Yu, G.Q., Mallory, M., Rockenstein, E.M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K. & McConlogue, L. (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci, 20, 4050-4058.

Nhan, H.S., Chiang, K. & Koo, E.H. (2015) The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes. Acta Neuropathol, 129, 1-19.

Palop, J.J. & Mucke, L. (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci, 13, 812-818.

Romberg, C., Raffel, J., Martin, L., Sprengel, R., Seeburg, P.H., Rawlins, J.N., Bannerman, D.M. & Paulsen, O. (2009) Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampus. Eur J Neurosci, 29, 1141-1152.

Russo, C., Dolcini, V., Salis, S., Venezia, V., Zambrano, N., Russo, T. & Schettini, G. (2002) Signal transduction through tyrosine-phosphorylated C-terminal fragments of amyloid precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain. J Biol Chem, 277, 35282-35288.

Sakamoto, K.M. & Frank, D.A. (2009) CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res, 15, 2583-2587.

Sanderson, D.J., Good, M.A., Skelton, K., Sprengel, R., Seeburg, P.H., Rawlins, J.N. & Bannerman, D.M. (2009) Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model. Learn Mem, 16, 379-386.

Saura, C.A., Chen, G., Malkani, S., Choi, S.Y., Takahashi, R.H., Zhang, D., Gouras, G.K., Kirkwood, A., Morris, R.G. & Shen, J. (2005) Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. J Neurosci, 25, 6755-6764.

Sevigny, J., Chiao, P., Bussière, T., Weinreb, P.H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., O'Gorman, J., Qian, F., Arastu, M., Li, M., Chollate, S., Brennan, M.S., Quintero-Monzon, O., Scannevin, R.H., Arnold, H.M., Engber, T., Rhodes, K., Ferrero, J., Hang, Y., Mikulskis, A., Grimm, J., Hock, C., Nitsch, R.M. & Sandrock, A. (2016) The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature, 537, 50-56.

Shankar, G.M., Bloodgood, B.L., Townsend, M., Walsh, D.M., Selkoe, D.J. & Sabatini, B.L. (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci, 27, 2866-2875.

Sharma, K., Pradhan, S., Duffy, L.K., Yeasmin, S., Bhattarai, N. & Schulte, M.K. (2021) Role of receptors in relation to plaques and tangles in Alzheimer's disease pathology. Int J Mol Sci, 22.

Shaywitz, A.J. & Greenberg, M.E. (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem, 68, 821-861.

Shi, X., Chen, Y.H., Liu, H. & Qu, H.D. (2016) Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice. Mol Med Rep, 14, 2397-2404.

Spencer, S. & Kalivas, P.W. (2017) Glutamate transport: A new bench to bedside mechanism for treating drug abuse. Int J Neuropsychopharmacol, 20, 797-812.

Sponne, I., Fifre, A., Drouet, B., Klein, C., Koziel, V., Pinçon-Raymond, M., Olivier, J.L., Chambaz, J. & Pillot, T. (2003) Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation. J Biol Chem, 278, 3437-3445.

Sun, A., Liu, M., Nguyen, X.V. & Bing, G. (2003) P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp Neurol, 183, 394-405.

Tu, S., Okamoto, S., Lipton, S.A. & Xu, H. (2014) Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease. Mol Neurodegener, 9, 48.

Yang, W.N., Ma, K.G., Chen, X.L., Shi, L.L., Bu, G., Hu, X.D., Han, H., Liu, Y. & Qian, Y.H. (2014) Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells. Neuroscience, 278, 276-290.

Yarza, R., Vela, S., Solas, M. & Ramirez, M.J. (2015) c-Jun N-terminal Kinase (JNK) signaling as a therapeutic target for Alzheimer's disease. Front Pharmacol, 6, 321.